含羞草社区

?
?
?
Home Tags Posts tagged with "Hong Kong IPO"

Tag: Hong Kong IPO

Firms act on snack retailer Busy Ming’s HKD3.67bn HKEX IPO

Snack retailer Busy Ming raised HKD 3.67 bn in its HKEX IPO. Clifford Chance, CM Law Firm, Cleary Gottlieb, Jingtian & Gongcheng and Han Kun advised on the transaction

Firms steer AI developer MiniMax’s HKD4.82bn Hong Kong IPO

Marking the largest IPO to date by an AI LLM company, advised by eight law firms

Firms guide Seres on debut, HK’s largest carmaker IPO in 2025

Seres Group raised USD1.83bn in its HKEX debut, Hong Kong’s largest carmaker IPO and third-biggest listing of 2025, advised by Davis Polk, KWM, Cooley, Haiwen and Han Kun

Embracing risk

As capital markets resurrect, how can businesses capitalise on opportunities amid risks and nagging uncertainties?

CATL’s HKD35.7bn HKEX debut reignites HK global IPO ambitions

CATL raised HKD35.7 billion in its Hong Kong debut, marking the city’s largest IPO in four years and accelerating the company’s global expansion

CATL’s HKD35.7bn HKEX debut reignites HK global IPO ambitions

China’s CATL raised HKD35.7 billion in Hong Kong’s largest IPO in four years, boosting its global expansion and the city’s fundraising stature

Chinese law firms make inroads on drafting prospectuses

In the last two months of 2023, at least three Chinese law firms have been writing prospectuses for IPOs in Hong Kong

Three law firms assist Weilong snack brand’s HKD898m Hong Kong IPO

Clifford Chance, Commerce & Finance Law Firm and Maples advised famous Chinese snack brand Weilong on its HKEX listing, raising HKD898 million from the sale of 96.4 million shares at HKD10.56 apiece

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

Three law firms guide smart drugs platform’s debut on Hong Kong bourse

A trio of law firms guided Chinese online pharmacy platform Dingdang Health in its Hong Kong IPO of ?HKD12 per share, raising HKD402.4 million (USD51 million)

Capital punishment

Chinese IPOs overseas have consistently outperformed those of other nations, but a rash of scandals and suspected frauds has threatened to end the bull run.

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW

Follow us on LinkedIn